Preservation of endothelium-dependent relaxation in atherosclerotic mice with endothelium-restricted endothelin-1 overexpression

Journal of Pharmacology and Experimental Therapeutics

Volumn 347, Issue 1, 2013, Pages 30-37

  Mian, Muhammad Oneeb Rehman ^a   Idris Khodja, Noureddine ^a   Li, Melissa W ^a   Leibowitz, Avshalom ^a   Paradis, Pierre ^a   Rautureau, Yohann ^a   Schiffrin, Ernesto L ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; ENDOTHELIN 1; GUANYLATE CYCLASE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN SYNTHASE; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ATHEROSCLEROSIS; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; ENZYME INHIBITION; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASODILATATION; WILD TYPE;

ANIMALS; ATHEROSCLEROSIS; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; ORGAN CULTURE TECHNIQUES; SEVERITY OF ILLNESS INDEX; VASODILATION;

EID: 84884624691     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.113.206532     Document Type: Conference Paper

References (50)

1. Amiri F, Paradis P, Reudelhuber TL, and Schiffrin EL (2008) Vascular inflammation in absence of blood pressure elevation in transgenic murine model overexpressing endothelin-1 in endothelial cells. J Hypertens 26:1102-1109.
2. Amiri F, Virdis A, Neves MF, Iglarz M, Seidah NG, Touyz RM, Reudelhuber TL, and Schiffrin EL (2004) Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction. Circulation 110:2233-2240.
3. Andrews KL, Irvine JC, Tare M, Apostolopoulos J, Favaloro JL, Triggle CR, and Kemp-Harper BK (2009) A role for nitroxyl (HNO) as an endothelium-derived relaxing and hyperpolarizing factor in resistance arteries. Br J Pharmacol 157: 540-550.
4. Barton M, Haudenschild CC, d'Uscio LV, Shaw S, Münter K, and Lüscher TF (1998) Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 95:14367-14372.
5. Beleznai T, Takano H, Hamill C, Yarova P, Douglas G, Channon K, and Dora K (2011) Enhanced K(1)-channel-mediated endothelium-dependent local and conducted dilation of small mesenteric arteries from ApoE(-/-) mice. Cardiovasc Res 92:199-208.
6. Bullen ML, Miller AA, Andrews KL, Irvine JC, Ritchie RH, Sobey CG, and Kemp-Harper BK (2011) Nitroxyl (HNO) as a vasoprotective signaling molecule. Antioxid Redox Signal 14:1675-1686.
7. Chan TS, Lin CX, Chan WY, Chung SS, and Chung SK (1995)Mouse preproendothelin-1 gene. cDNA cloning, sequence analysis and determination of sites of expression during embryonic development. Eur J Biochem 234:819-826.
8. Chauhan S, Rahman A, Nilsson H, Clapp L, MacAllister R, and Ahluwalia A (2003) NO contributes to EDHF-like responses in rat small arteries: a role for NO stores. Cardiovasc Res 57:207-216.
9. Cohen RA, Plane F, Najibi S, Huk I, Malinski T, and Garland CJ (1997) Nitric oxide is the mediator of both endothelium-dependent relaxation and hyperpolarization of the rabbit carotid artery. Proc Natl Acad Sci USA 94:4193-4198.
10. Cox RH (2005) Molecular determinants of voltage-gated potassium currents in vascular smooth muscle. Cell Biochem Biophys 42:167-195.
11. d'Uscio LV, Baker TA, Mantilla CB, Smith L, Weiler D, Sieck GC, and Katusic ZS (2001) Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 21:1017-1022.
12. d'Uscio LV, Barton M, Shaw S, and Lüscher TF (2002) Chronic ET(A) receptor blockade prevents endothelial dysfunction of small arteries in apolipoprotein Edeficient mice. Cardiovasc Res 53:487-495.
13. Danser AH, de Vries R, Schoemaker RG, and Saxena PR (1998) Bradykinin-induced release of nitric oxide by the isolated perfused rat heart: importance of preformed pools of nitric oxide-containing factors. J Hypertens 16:239-244.
14. Diep QN, El Mabrouk M, Cohn JS, Endemann D, Amiri F, Virdis A, Neves MF, and Schiffrin EL (2002) Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma. Circulation 105:2296-2302.
15. Ding H, Hashem M, Wiehler WB, Lau W, Martin J, Reid J, and Triggle C (2005) Endothelial dysfunction in the streptozotocin-induced diabetic apoE-deficient mouse. Br J Pharmacol 146:1110-1118.
16. Edwards G, Dora KA, Gardener MJ, Garland CJ, and Weston AH (1998) K+ is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 396:269-272.
17. Edwards G, Félétou M, and Weston AH (2010) Endothelium-derived hyperpolarising factors and associated pathways: a synopsis. Pflugers Arch 459:863-879.
18. Félétou M and Vanhoutte PM (2013) Endothelium-dependent hyperpolarization: no longer an f-word! J Cardiovasc Pharmacol 61:91-92.
19. Félétou M, Vanhoutte PM, Weston AH, and Edwards G (2003) EDHF and endothelial potassium channels: IKCa and SKCa. Br J Pharmacol 140:225-, author reply 226.
20. Foresti R, Hammad J, Clark JE, Johnson TR, Mann BE, Friebe A, Green CJ, and Motterlini R (2004) Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule. Br J Pharmacol 142:453-460.
21. Freiman PC, Mitchell GG, Heistad DD, Armstrong ML, and Harrison DG (1986) Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ Res 58:783-789.
22. Gauthier KM, Deeter C, Krishna UM, Reddy YK, Bondlela M, Falck JR, and Campbell WB (2002) 14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries. Circ Res 90:1028-1036.
23. Hosoya M, Ohashi J, Sawada A, Takaki A, and Shimokawa H (2010) Combination therapy with olmesartan and azelnidipine improves EDHF-mediated responses in diabetic apolipoprotein E-deficient mice. Circ J 74:798-806.
24. Javeshghani D, Barhoumi T, Idris-Khodja N, Paradis P, and Schiffrin EL (2013) Reduced macrophage-dependent inflammation improves endothelin-1-induced vascular injury. Hypertension 62:112-117.
25. Ko EA, Han J, Jung ID, and Park WS (2008) Physiological roles of K+ channels in vascular smooth muscle cells. J Smooth Muscle Res 44:65-81.
26. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, and Harrison DG (2001) Endothelial regulation of vasomotion in apoEdeficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103:1282-1288.
27. Lee MY, Li H, Xiao Y, Zhou Z, Xu A, and Vanhoutte PM (2011) Chronic administration of BMS309403 improves endothelial function in apolipoprotein Edeficient mice and in cultured human endothelial cells. Br J Pharmacol 162: 1564-1576.
28. Leibovitz E, Ebrahimian T, Paradis P, and Schiffrin EL (2009) Aldosterone induces arterial stiffness in absence of oxidative stress and endothelial dysfunction. J Hypertens 27:2192-2200.
29. Leo MD, Siddegowda YK, Kumar D, Tandan SK, Sastry KV, Prakash VR, and Mishra SK (2008) Role of nitric oxide and carbon monoxide in N(omega)-Nitro-L-arginine methyl ester-resistant acetylcholine-induced relaxation in chicken carotid artery. Eur J Pharmacol 596:111-117.
30. Lerman A, Holmes DR, Jr, Bell MR, Garratt KN, Nishimura RA, and Burnett JC, Jr (1995) Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 92:2426-2431.
31. Leung JW, Wong WT, Koon HW, Mo FM, Tam S, Huang Y, Vanhoutte PM, Chung SS, and Chung SK (2011) Transgenic mice over-expressing ET-1 in the endothelial cells develop systemic hypertension with altered vascular reactivity. PLoS ONE 6: e26994.
32. Li JS, Larivière R, and Schiffrin EL (1994) Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats: evidence for a role of endothelin in vascular hypertrophy. Hypertension 24: 183-188.
33. Lundberg JO, Weitzberg E, and Gladwin MT (2008) The nitrate-nitrite- nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 7:156-167.
34. McCulloch AI, Bottrill FE, Randall MD, and Hiley CR (1997) Characterization and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bed. Br J Pharmacol 120:1431-1438.
35. Morikawa K, Matoba T, Kubota H, Hatanaka M, Fujiki T, Takahashi S, Takeshita A, and Shimokawa H (2005) Influence of diabetes mellitus, hypercholesterolemia, and their combination on EDHF-mediated responses in mice. J Cardiovasc Pharmacol 45:485-490.
36. Ng ES, Cheng ZJ, Ellis A, Ding H, Jiang Y, Li Y, Hollenberg MD, and Triggle CR (2007) Nitrosothiol stores in vascular tissue: modulation by ultraviolet light, acetylcholine and ionomycin. Eur J Pharmacol 560:183-192.
37. Ohashi J, Sawada A, Nakajima S, Noda K, Takaki A, and Shimokawa H (2012) Mechanisms for enhanced endothelium-derived hyperpolarizing factor-mediated responses in microvessels in mice. Circ J 76:1768-1779.
38. Plump AS, Smith JD, Hayek T, Aalto-Setälä K, Walsh A, Verstuyft JG, Rubin EM, and Breslow JL (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71:343-353.
39. Prysyazhna O, Rudyk O, and Eaton P (2012) Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertension. Nat Med 18: 286-290.
40. Rautureau Y and Schiffrin EL (2012) Endothelin in hypertension: an update. Curr Opin Nephrol Hypertens 21:128-136.
41. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809.
42. Schiffrin EL (2005) Vascular endothelin in hypertension. Vascul Pharmacol 43: 19-29.
43. Schiffrin EL, Larivière R, Li JS, and Sventek P (1996) Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure. J Vasc Res 33:235-248.
44. Simeone SM, Li MW, Paradis P, and Schiffrin EL (2011) Vascular gene expression in mice overexpressing human endothelin-1 targeted to the endothelium. Physiol Genomics 43:148-160.
45. Takaki A, Morikawa K, Tsutsui M, Murayama Y, Tekes E, Yamagishi H, Ohashi J, Yada T, Yanagihara N, and Shimokawa H (2008) Crucial role of nitric oxide synthases system in endothelium-dependent hyperpolarization in mice. J Exp Med 205:2053-2063.
46. Vanhoutte PM, Shimokawa H, Tang EH, and Feletou M (2009) Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 196:193-222.
47. Wynne BM, Labazi H, Tostes RC, and Webb RC (2012) Aorta from angiotensin II hypertensive mice exhibit preserved nitroxyl anion mediated relaxation responses. Pharmacol Res 65:41-47.
48. Yoon MH, Reriani M, Mario G, Rihal C, Gulati R, Lennon R, Tilford JM, Lerman LO, and Lerman A (2013) Long-term endothelin receptor antagonism attenuates coronary plaque progression in patients with early atherosclerosis. Int J Cardiol DOI: 10.1016/j.ijcard.2012.12.001.
49. Zhao Y, Vanhoutte PM, and Leung SW (2013) Endothelial nitric oxide synthaseindependent release of nitric oxide in the aorta of the spontaneously hypertensive rat. J Pharmacol Exp Ther 344:15-22.
50. Zheng X, Ying L, Liu J, Dou D, He Q, Leung SW, Man RY, Vanhoutte PM, and Gao Y (2011) Role of sulfhydryl-dependent dimerization of soluble guanylyl cyclase in relaxation of porcine coronary artery to nitric oxide. Cardiovasc Res 90: 565-572.